Controlling Hypertension in Patients with Diabetes
Overview
Affiliations
Hypertension and diabetes mellitus are common diseases in the United States. Patients with diabetes have a much higher rate of hypertension than would be expected in the general population. Regardless of the antihypertensive agent used, a reduction in blood pressure helps to prevent diabetic complications. Barring contraindications, angiotensin-converting enzyme inhibitors are considered first-line therapy in patients with diabetes and hypertension because of their well-established renal protective effects. Calcium channel blockers, low-dose diuretics, beta blockers, and alpha blockers have also been studied in this group. Most diabetic patients with hypertension require combination therapy to achieve optimal blood pressure goals.
Alawneh I, Yasin A, Musmar S Adv Med. 2022; 2022:5319756.
PMID: 36062140 PMC: 9436595. DOI: 10.1155/2022/5319756.
Syed A, Reddy G, Ghosh D, Prada M, Nystoriak M, Morotti S J Clin Invest. 2019; 129(8):3140-3152.
PMID: 31162142 PMC: 6668679. DOI: 10.1172/JCI124705.
Drug interactions of meglitinide antidiabetics involving CYP enzymes and OATP1B1 transporter.
Maideen N, Manavalan G, Balasubramanian K Ther Adv Endocrinol Metab. 2018; 9(8):259-268.
PMID: 30181852 PMC: 6116761. DOI: 10.1177/2042018818767220.
Evaluation and Use of Registry Data in a GIS Analysis of Diabetes.
Kameel M, Steven S, Aleem K, Dayna L, Demeytri R, Shanala S AIMS Public Health. 2018; 2(3):318-331.
PMID: 29546113 PMC: 5690238. DOI: 10.3934/publichealth.2015.3.318.
Medicare Star excludes diabetes patients with poor CVD risk factor control.
Schmittdiel J, Raebel M, Dyer W, Steiner J, Goodrich G, Karter A Am J Manag Care. 2015; 20(12):e573-81.
PMID: 25741874 PMC: 4641517.